Wandercraft: The Future of Mobility is Here
June 12, 2025, 3:31 pm
Location: France, Ile-of-France, Paris
Employees: 51-200
Founded date: 2012
Total raised: $120.38M
In the heart of Paris, a revolution is brewing. Wandercraft, a robotics company, is transforming the landscape of mobility. With a recent funding boost of €64.3 million, the company is poised to shift gears from hospitals to homes and factories. This is not just about robots; it’s about redefining human movement.
Founded in 2012, Wandercraft has carved a niche in the world of robotics. Its flagship product, the Atalante X, is a clinical exoskeleton that has already made waves in over 100 hospitals worldwide. This device has helped thousands regain their ability to walk, a feat once thought impossible for many. The company’s mission is clear: to restore independence and mobility to those who need it most.
The latest funding round, which saw participation from heavyweights like Renault Group and Bpifrance, marks a significant milestone. This capital will fuel Wandercraft’s ambitious plans to bring its latest innovation, Eve, to market by 2026. Eve is not just another exoskeleton; it’s the world’s first self-balancing personal exoskeleton. Imagine walking upright without crutches or walkers. That’s the promise of Eve.
Eve is designed for individuals with severe mobility impairments. It’s powered by artificial intelligence, refined through billions of simulations and millions of real-world steps. This isn’t just a gadget; it’s a lifeline. Clinical trials are already underway, and the excitement is palpable. The goal is to make mobility accessible in everyday life, not just in clinical settings.
But Wandercraft isn’t stopping there. The partnership with Renault is a game-changer. Renault, a titan in the automotive industry, is not just an investor; they are also Wandercraft’s first commercial customer for Calvin-40, an industrial humanoid robot. Calvin-40 is designed for strenuous factory tasks, showcasing the potential of robotics in industrial settings. Developed in just 40 days, this robot is a testament to Wandercraft’s rapid innovation capabilities.
The collaboration with Renault opens doors. It allows Wandercraft to leverage Renault’s manufacturing expertise, ensuring that both Eve and Calvin-40 can be produced at scale. This partnership is a bridge between healthcare and industry, merging the worlds of rehabilitation and robotics.
Wandercraft’s journey has been marked by significant achievements. The Atalante X has received FDA clearances for stroke rehabilitation, proving its efficacy in clinical settings. With over 20 clinical studies backing its effectiveness, the exoskeleton has shown measurable improvements in gait, balance, and muscular strength. More than 2,500 users have taken over 14 million steps, rediscovering the joy of movement.
The company’s expansion into the U.S. market has been nothing short of explosive. Following a €39.2 million Series C round, Wandercraft opened its first U.S. walk center in New York City. This facility is not just a clinic; it’s a hub for innovation and rehabilitation. It aims to be the first regional center for Eve’s deployment, setting the stage for a broader rollout.
Wandercraft’s vision extends beyond rehabilitation. The company is also focused on industrial applications. The Calvin series of humanoid robots is designed to assist in physically demanding tasks, relieving workers from hazardous labor. This dual focus on healthcare and industry positions Wandercraft as a leader in the robotics space.
The road ahead is filled with promise. Wandercraft is not just about technology; it’s about humanity. The company believes that everyone deserves the chance to move freely. Its mission is to connect robotics with people, ensuring that technology serves a purpose.
As Wandercraft continues to innovate, it invites individuals to join its journey. The company is on the lookout for passionate, mission-driven individuals to help shape the future of mobility. From robot control to machine learning, there are opportunities for those eager to tackle complex challenges.
In a world where mobility is often taken for granted, Wandercraft is a beacon of hope. The company’s advancements in robotics are not just technical achievements; they are life-changing innovations. With Eve and Calvin-40 on the horizon, the future of mobility is bright.
Wandercraft is not just building robots; it’s building a future where movement is a right, not a privilege. The company’s commitment to restoring independence and enhancing quality of life is a testament to the power of technology. As we look ahead, one thing is clear: the journey of Wandercraft is just beginning, and the world is watching.
Founded in 2012, Wandercraft has carved a niche in the world of robotics. Its flagship product, the Atalante X, is a clinical exoskeleton that has already made waves in over 100 hospitals worldwide. This device has helped thousands regain their ability to walk, a feat once thought impossible for many. The company’s mission is clear: to restore independence and mobility to those who need it most.
The latest funding round, which saw participation from heavyweights like Renault Group and Bpifrance, marks a significant milestone. This capital will fuel Wandercraft’s ambitious plans to bring its latest innovation, Eve, to market by 2026. Eve is not just another exoskeleton; it’s the world’s first self-balancing personal exoskeleton. Imagine walking upright without crutches or walkers. That’s the promise of Eve.
Eve is designed for individuals with severe mobility impairments. It’s powered by artificial intelligence, refined through billions of simulations and millions of real-world steps. This isn’t just a gadget; it’s a lifeline. Clinical trials are already underway, and the excitement is palpable. The goal is to make mobility accessible in everyday life, not just in clinical settings.
But Wandercraft isn’t stopping there. The partnership with Renault is a game-changer. Renault, a titan in the automotive industry, is not just an investor; they are also Wandercraft’s first commercial customer for Calvin-40, an industrial humanoid robot. Calvin-40 is designed for strenuous factory tasks, showcasing the potential of robotics in industrial settings. Developed in just 40 days, this robot is a testament to Wandercraft’s rapid innovation capabilities.
The collaboration with Renault opens doors. It allows Wandercraft to leverage Renault’s manufacturing expertise, ensuring that both Eve and Calvin-40 can be produced at scale. This partnership is a bridge between healthcare and industry, merging the worlds of rehabilitation and robotics.
Wandercraft’s journey has been marked by significant achievements. The Atalante X has received FDA clearances for stroke rehabilitation, proving its efficacy in clinical settings. With over 20 clinical studies backing its effectiveness, the exoskeleton has shown measurable improvements in gait, balance, and muscular strength. More than 2,500 users have taken over 14 million steps, rediscovering the joy of movement.
The company’s expansion into the U.S. market has been nothing short of explosive. Following a €39.2 million Series C round, Wandercraft opened its first U.S. walk center in New York City. This facility is not just a clinic; it’s a hub for innovation and rehabilitation. It aims to be the first regional center for Eve’s deployment, setting the stage for a broader rollout.
Wandercraft’s vision extends beyond rehabilitation. The company is also focused on industrial applications. The Calvin series of humanoid robots is designed to assist in physically demanding tasks, relieving workers from hazardous labor. This dual focus on healthcare and industry positions Wandercraft as a leader in the robotics space.
The road ahead is filled with promise. Wandercraft is not just about technology; it’s about humanity. The company believes that everyone deserves the chance to move freely. Its mission is to connect robotics with people, ensuring that technology serves a purpose.
As Wandercraft continues to innovate, it invites individuals to join its journey. The company is on the lookout for passionate, mission-driven individuals to help shape the future of mobility. From robot control to machine learning, there are opportunities for those eager to tackle complex challenges.
In a world where mobility is often taken for granted, Wandercraft is a beacon of hope. The company’s advancements in robotics are not just technical achievements; they are life-changing innovations. With Eve and Calvin-40 on the horizon, the future of mobility is bright.
Wandercraft is not just building robots; it’s building a future where movement is a right, not a privilege. The company’s commitment to restoring independence and enhancing quality of life is a testament to the power of technology. As we look ahead, one thing is clear: the journey of Wandercraft is just beginning, and the world is watching.